SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-18-341159
Filing Date
2018-12-03
Accepted
2018-12-03 16:36:35
Documents
8

Document Format Files

Seq Description Document Type Size
1 S-3 d664215ds3.htm S-3 487132
2 EX-1.2 d664215dex12.htm EX-1.2 150246
3 EX-4.5 d664215dex45.htm EX-4.5 548621
4 EX-4.6 d664215dex46.htm EX-4.6 588800
5 EX-5.1 d664215dex51.htm EX-5.1 13968
6 EX-5.2 d664215dex52.htm EX-5.2 6961
7 EX-23.1 d664215dex231.htm EX-23.1 2004
8 GRAPHIC g664215g39h59.jpg GRAPHIC 33505
  Complete submission text file 0001193125-18-341159.txt   1845053
Mailing Address ONE NEWTON EXECUTIVE PARK SUITE 202 NEWTON MA 02462
Business Address ONE NEWTON EXECUTIVE PARK SUITE 202 NEWTON MA 02462 617-467-4577
Allena Pharmaceuticals, Inc. (Filer) CIK: 0001624658 (see all company filings)

IRS No.: 452729920 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-228656 | Film No.: 181214387
SIC: 2836 Biological Products, (No Diagnostic Substances)